FR2366276B1 - - Google Patents

Info

Publication number
FR2366276B1
FR2366276B1 FR7705105A FR7705105A FR2366276B1 FR 2366276 B1 FR2366276 B1 FR 2366276B1 FR 7705105 A FR7705105 A FR 7705105A FR 7705105 A FR7705105 A FR 7705105A FR 2366276 B1 FR2366276 B1 FR 2366276B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7705105A
Other versions
FR2366276A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit SpA filed Critical Lepetit SpA
Publication of FR2366276A1 publication Critical patent/FR2366276A1/fr
Application granted granted Critical
Publication of FR2366276B1 publication Critical patent/FR2366276B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
FR7705105A 1976-02-23 1977-02-22 Aza-13 prostaglandines Granted FR2366276A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7043/76A GB1553293A (en) 1976-02-23 1976-02-23 Azaprostaglandins

Publications (2)

Publication Number Publication Date
FR2366276A1 FR2366276A1 (fr) 1978-04-28
FR2366276B1 true FR2366276B1 (fr) 1981-11-27

Family

ID=9825554

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7705105A Granted FR2366276A1 (fr) 1976-02-23 1977-02-22 Aza-13 prostaglandines

Country Status (6)

Country Link
US (1) US4182903A (fr)
JP (1) JPS52102253A (fr)
CA (1) CA1100955A (fr)
DE (1) DE2705797A1 (fr)
FR (1) FR2366276A1 (fr)
GB (1) GB1553293A (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7905375A (nl) * 1978-07-11 1980-01-15 Glaxo Group Ltd Prostanoiden, werkwijze voor het bereiden daarvan, en daarop gebaseerde farmaceutische preparaten.
US4438111A (en) 1980-01-09 1984-03-20 Glaxo Group Limited Prostanoid compounds and pharmaceutical formulations
ZA81114B (en) 1980-01-09 1982-01-27 Glaxo Group Ltd Prostanoid compounds and their preparation and pharmaceutical formalation
IL62734A (en) * 1980-04-30 1985-10-31 Glaxo Group Ltd Aminocyclopentane alkenoic acids and esters,their preparation and pharmaceutical formulations
US4371530A (en) * 1980-07-04 1983-02-01 Glaxo Group Limited Aminocyclopentanone amides and pharmaceutical formulation
DE3162659D1 (en) * 1980-07-22 1984-04-19 Ono Pharmaceutical Co 9,11-methano-13-aza-11a-carbathrombanoic acid analogues and pharmaceutical use thereof
CA1191134A (fr) * 1981-04-29 1985-07-30 Eric W. Collington Acides et esters de l'aminocyclopentanol, leur preparation et leur formule pharmaceutique
IL67041A (en) * 1981-10-29 1988-03-31 Glaxo Group Ltd 2-aminocyclopentane alkanoic and alkenoic acid esters,process for their preparation and pharmaceutical compositions containing them
DE3610952A1 (de) * 1986-04-02 1987-10-08 Hagen Batterie Ag Verfahren zum herstellen von akkumulatoren mit akkumulatorplattensaetzen und nach diesem verfahren hergestellter akkumulator
JPS63207058A (ja) * 1987-02-24 1988-08-26 Shin Kobe Electric Mach Co Ltd 密閉形蓄電池の製造法
US6417228B1 (en) 1998-11-02 2002-07-09 Alcon Manufacturing, Ltd.. 13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension

Also Published As

Publication number Publication date
JPS6113469B2 (fr) 1986-04-14
DE2705797A1 (de) 1977-09-01
FR2366276A1 (fr) 1978-04-28
CA1100955A (fr) 1981-05-12
US4182903A (en) 1980-01-08
JPS52102253A (en) 1977-08-27
GB1553293A (en) 1979-09-26

Similar Documents

Publication Publication Date Title
FR2349768B1 (fr)
IN147439B (fr)
FR2344195B1 (fr)
JPS577149B2 (fr)
FR2343888B3 (fr)
JPS52167939U (fr)
JPS564853Y2 (fr)
JPS5366196U (fr)
JPS5355458U (fr)
JPS5321614U (fr)
JPS5390053U (fr)
JPS52125224U (fr)
JPS5395427U (fr)
CS175505B1 (fr)
CS175315B1 (fr)
CS175525B1 (fr)
CS178381B1 (fr)
DD123550A1 (fr)
CH613075A5 (fr)
DD124183A1 (fr)
DD124160A1 (fr)
DD124028A1 (fr)
DD124009A1 (fr)
DD123680A1 (fr)
DD124429A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse